ABIOMED is a provider of medical devices that provide circulatory support and oxygenation. Co.'s existing products include: Impella 2.5®, which is a percutaneous heart pump with a motor and sensors; Impella CP®, which is primarily used by either interventional cardiologists to support patients in the cath lab or by cardiac surgeons in the heart surgery suite; Impella 5.0® and Impella LD®, which are percutaneous heart pumps with motors and sensors for use primarily in the heart surgery suite; Impella 5.5®, which is designed to be a percutaneous heart pump with motors and sensors; and Abiomed Breethe OXY-1 System, which is a portable external respiratory assistance device. When considering the ABIOMED, Inc. stock dividend history, we have taken known splits into account, such that the ABMD dividend history is presented on a split-adjusted ("apples to apples") basis. ABIOMED, Inc. dividend history is presented both in graphical/chart form, and as a ABMD dividend history data table along the right-hand column.
|
ABMD Stock Dividend HistoryThe ABMD dividend history graphic shown above is presented after taking into consideration any known stock split occurrences, in order to present the most directly comparable ABMD historical dividend comparison possible. Historical dividends, when charted graphically, can reveal the long-term variability and/or growth within the ABMD dividend history record. Also see the ABMD stock dividend history data table along the right-hand column below. |
|
|
Hold (2.40 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Analysts' Target Price: ABMD Forecast Based on data provided by Zacks Investment Research via Quandl.com |